Clot-Busting drugs may cut death risk in lung clot patients

This study looked at whether giving clot-busting drugs (thrombolysis) to people with a serious but not immediately life-threatening type of lung clot (pulmonary embolism) and a low risk of bleeding could lower their chance of dying within 30 days. The study included 100 patients and tracked deaths and major bleeding events. The goal was to see if the benefits of breaking up the clot outweigh the risks of bleeding.